TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
Kappa Bioscience AS
Closing information (x1000 DKK)
Closing information | 2022/12 | 2021/12 | 2020/12 (consolidated) |
Turnover | 206,355 | 173,033 | 209,575 |
Financial expenses | 15,715 | 32,766 | 11,762 |
Earnings before taxes | 47,546 | 51,421 | 61,356 |
Total assets | 332,720 | 267,129 | 204,848 |
Current assets | 151,714 | 191,680 | 137,710 |
Current liabilities | 102,895 | 68,005 | 63,693 |
Equity capital | 179,495 | 171,638 | 135,175 |
- share capital | 1,074 | 1,134 | 1,076 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 (consolidated) |
Solvency | 53.9% | 64.3% | 66.0% |
Turnover per employee | |||
Profit as a percentage of turnover | 23.0% | 29.7% | 29.3% |
Return on assets (ROA) | 19.0% | 31.5% | 35.7% |
Current ratio | 147.4% | 281.9% | 216.2% |
Return on equity (ROE) | 26.5% | 30.0% | 45.4% |
Change turnover | 42,411 | -47,834 | 65,965 |
Change turnover % | 26% | 46% | |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 (consolidated) |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.